Condition: Endometriosis · Endometriosis-related Pain · Endometriosis Pelvic · Sponsor: TriHealth Inc.
To our knowledge, no other human studies directly compare the effectiveness of the various ablative technologies. We set out to design a study to directly compare ablative energy sources and evaluate their ability to destroy native endometriosis tissue in humans.
This description comes directly from the study's public registry record.
Devin Namaky, MD · 513-862-1888 · devin_namaky@trihealth.com
Always discuss trial participation with your own doctor first.
| Good Samaritan Hospital | Cincinnati, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06414083